Showing results (201-210 of 15,737) with videos related to

Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Characterization of MRSA in Canada from 2007 to 2016Kimberly A Nichol, Heather J Adam, George R Golding, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1985
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acidC H Teoh-Chan, A Cowlishaw, A Eley, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1985
In-vitro activity of methicillin against clinical isolates of Staphylococcus aureusN Frimodt-Møller, S H Hartzen, F Espersen
The Journal of Antimicrobial Chemotherapy|August 14, 2019
Towards endemicity: large-scale expansion of the NDM-1-producing Klebsiella pneumoniae ST11 lineage in Poland, 2015-16A Baraniak, M Machulska, D Żabicka, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1988
The penetration of fleroxacin into bronchial mucosaR Wise, D Honeybourne, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1988
In-vitro activity of ofloxacin against isolates of Neisseria gonorrhoeaeA McEwen, G Roberts
The Journal of Antimicrobial Chemotherapy|October 4, 2019
Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MSLaurent Dortet, Agnieszka Broda, Sandrine Bernabeu, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2019
Factors associated with the number of drugs in darunavir/cobicistat regimensEsteban Martinez, Eugenia Negredo, Hernando Knobel, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2019
Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 daysLeif Tueffers, Camilo Barbosa, Ingrid Bobis, et al.
Pageof 1,574